QCM
TEVA icon

Quantinno Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Quantinno Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10M Buy
296,251
+79,790
+37% +$2.66M 0.01% 983
2026
Q1 		$6.52M Buy
216,461
+25,349
+13% +$816K 0.01% 1035
2025
Q4 		$5.96M Buy
191,112
+33,892
+22% +$835K 0.01% 973
2025
Q3 		$3.18M Buy
157,220
+79,716
+103% +$1.4M 0.01% 1072
2025
Q2 		$1.3M Buy
77,504
+23,471
+43% +$379K 0.01% 1229
2025
Q1 		$830K Buy
54,033
+10,936
+25% +$195K 0.01% 1207
2024
Q4 		$950K Buy
43,097
+6,952
+19% +$126K 0.01% 1062
2024
Q3 		$651K Buy
36,145
+9,269
+34% +$162K 0.01% 1058
2024
Q2 		$437K Buy
26,876
+8,050
+43% +$124K 0.01% 1066
2024
Q1 		$266K Buy
18,826
+6,497
+53% +$81.9K 0.01% 1113
2023
Q4 		$129K Buy
+12,329
New +$115K ﹤0.01% 1066

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Quantinno Capital Management's TEVA Position: Q2 2026 in Review

Quantinno Capital Management increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 37% in Q2 2026, buying an estimated $2.66M and bringing the position to 296,251 shares worth $10M. The position accounts for 0.01% of the portfolio, ranked #983.

Quantinno Capital Management first reported a position in TEVA in Q4 2023 and has held it in 11 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Quantinno Capital Management held 296,251 shares of Teva Pharmaceutical Industries Limited worth $10M as of Q2 2026.
  • Quantinno Capital Management bought 79,790 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $2.66M.
  • Teva Pharmaceutical Industries Limited made up 0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #983 holding.
  • Quantinno Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2023 and has held it in 11 quarters since.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.